Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
514 |
|
| Actual shortage: | 72 (14%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 14 (3%) | |
| Resolved: | 413 (80%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 8 (12%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 10 (14%) | |
Late reports |
52 (9%) |
|
Overdue reports |
24 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211071 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211074 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216254 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-13 | 216259 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-17 | 2024-06-06 | 216267 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-30 | 2024-05-17 | 217783 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2024-02-26 | 2024-06-19 | 220627 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-02-26 | 2024-05-02 | 220633 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-02-26 | 2024-06-19 | 220643 |
| DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-03-11 | 2024-04-23 | 221877 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-25 | 2024-04-23 | 223214 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2024-03-25 | 2024-08-03 | 223259 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-05-28 | 2024-06-05 | 228955 |
| GABAPENTIN | 100MG | CAPSULE | Actual shortage | 2024-05-28 | 2024-07-15 | 228997 |
| PROGESTERONE | 100MG | CAPSULE | Avoided shortage | 2024-05-28 | 2024-05-30 | 229006 |
| AMOXICILLIN CAPSULES BP | 500MG | CAPSULE | Actual shortage | 2024-05-28 | 2024-07-02 | 229018 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2024-07-03 | 2024-07-31 | 232054 |
| SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-07-22 | 2024-09-18 | 233530 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SOLIFENACIN | 10MG | TABLET | To be discontinued | 2024-07-24 | 2024-07-24 | 233602 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |